Concepedia

Teilo Schaller

TS

Statistics

Publications

8

Citations

850

H-Index

8

Active since

2016

Affiliations

Duke University(Current)

Duke Medical Center

American Society of Clinical Oncology

Institute for Biomedical Engineering

Harvard University

Teilo Schaller is an author at Duke University specializing in oncology, cancer immunotherapy, and tumor immunology.

Publications per year

2016–2023

8

Publications

8

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Marina Bacac, Tanja Fauti, Johannes Sam et al. · Clinical Cancer Research · 2016 · 355 citations · Full text

Pharmacy, Immunology, Oncology +17

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

Amanda C. Guidon, Leeann B Burton, Bart K. Chwalisz et al. · Journal for ImmunoTherapy of Cancer · 2021 · 215 citations · Full text

Medicine, Neurology, Oncology +17

<i>In Vivo</i> Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell–Mediated Tumor Killing

Steffi Lehmann, Ramanil Perera, Hans-Peter Grimm et al. · Clinical Cancer Research · 2016 · 69 citations

Medicine, Immunology, Oncology +17

Challenges to Using Big Data in Cancer

Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams et al. · Cancer Research · 2023 · 60 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

Patrick C. Gedeon, Teilo Schaller, Satish K. Chitneni et al. · Clinical Cancer Research · 2018 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 8